Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation

Ralf Baelder*, Barbara Fuchs, Wilfried Bautsch, Joerg Zwirner, Jörg Köhl, Heinz G. Hoymann, Thomas Glaab, Veit J. Erpenbeck, Norbert Krug, Armin Braun

*Corresponding author for this work
86 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation'. Together they form a unique fingerprint.

Medicine & Life Sciences